In line with our findings, flow cytometry studies of untreated NSCLCs by Koppensteiner et al. could show that CD39 is mainly expressed in natural killer cells, tumor-associated fibroblasts, and T-cells, i.e., cells of the TME, but less so in the tumor cells themselves. The gene discussed is ENTPD1; the disease is neoplasm.